UNSPSC 51421905: Cortisone aceticum

This classification denotes a therapeutic glucocorticoid with the molecular formula C23H30O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 883WKN7W8X, chemically known as 4-pregnene-3,11,20-trione, 17alpha,21-dihydroxy-, 21-acetate but more generally known as cortisone acetate, which bears US NIH Compound Identifier 2863. European Medicines Agency schedules Cortisone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01467MIG.

Most nations, for tariff and trade purposes, schedule cortisone aceticum under HS 29372100. SMILES: CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O.

UNSPSC 51421905 Cortisone aceticum is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent opportunities tagged under it do not align cleanly with the code's nominal scope. The two most recent postings — a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs — involve pharmaceutical distribution and pharmacy benefit management rather than cortisone aceticum specifically. The code appears to serve as a catch-all for state and local pharmaceutical product and service procurement when more specific commodity codes are unavailable or misapplied. Issuing bodies include county health departments and state health and human services agencies. The naloxone procurement represents a straightforward product buy driven by community health initiatives, while the Texas RFI signals movement toward alternative pharmaceutical supply-chain models that bypass traditional pharmacy benefit managers and group purchasing organizations.

Activity under this code concentrates in Florida and Texas based on the recent record. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; responses were due July 26, 2023, and the contract carried a two-year initial term with a one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capability information on direct-to-manufacturer prescription fulfillment programs designed to improve cost management and fulfillment efficiency outside traditional PBM and GPO relationships; no formal response deadline or award timeline was specified. Neither solicitation specified set-aside designations. The code shows sparse recent activity overall, and the mismatch between the code's name and the actual scope of these opportunities suggests that state and local procurement offices may be applying this code inconsistently or as a fallback when pharmaceutical purchases do not fit other available taxonomy options.